Continuing Concerns Over Imported Pharmaceuticals: June 7, 2001

Committee Hearing
The Committee on Energy and Commerce
W.J. "Billy" Tauzin, Chairman

Continuing Concerns Over Imported Pharmaceuticals

Subcommittee on Oversight and Investigations
June 7, 2001
10:00 AM
2123 Rayburn House Office Building

Panel 1

Rev. and Mrs. Edwin Rode
405 Brookwood Drive
Athens, Georgia, 30605

Panel 2

Dr. Donald Vereen
Office of National Drug Control Policy
Executive Office of the President
Washington, DC, 20503 Ms. Laura Nagel
Drug Enforcement Administration
700 Army Navy Drive
Arlington, Virginia, 22202
Ms. Elizabeth Durant
U.S. Customs Service
Customs Headquarters, Room 4.4A
1300 Pennsylvania Ave., N.W
Washington, DC, 20229 Mr. William Hubbard
Food and Drug Administration
5600 Fishers Lane
Rockville, Maryland, 20857
Dr. Alan I. Leshner
Director
National Institute on Drug Abuse
6001 Executive Boulevard, Suite 524
Bethesda, Maryland, 20892 Mr. Landon Gibbs
First Sergeant
Virginia State Police
P.O. Box 978
Salem, Virginia, 24153

Panel 3

Dr. Marven Shepherd
Prefessor
University of Texas
Campus Mail Code: A 193
Austin, Texas, 78712 Dr. John D. Glover
Vice President, Corporate Security
Bristol-Myers Squibb Company
655 15th Street, N.W., Suite 300
Washington, D.C., 20005
Mr. James Christian
Vice President and Head of Corporate Security
Novartis International AG
701 Pennsylvania Avenue, N.W., Suite 725
Washington, D.C., 20004 Mr. William Trundley
Vice President
Corporate Security and Investigations
GlaxoSmithKline
1500 K Street, N.W., Suite 650
Washington, D.C., 20005
Mr. Gene R. Haislip
P.O. Box 941
Leesburg, Virginia, 20178 Mr. Donald deKieffer
deKieffer & Horgan
729 15th Street, N.W., Suite 800
Washington, D.C., 20005

Member Statements

The Honorable Jim Greenwood

The Honorable Billy Tauzin

Hearing Transcript: Printed

The printed transcript of this hearing is available in both Adobe Acrobat and text/html versions.

Click here to access the Adobe Acrobat version. You will need to the free Adobe Acrobat Reader to view this document. You can download the free Adobe Reader here.

Click here to access the text/html version. The text only version omits items, such charts, graphs and other documents that are part of the official printed hearing record.

Hearing Webcast Status: Complete

The broadcast has concluded. The archive will be available here as soon as possible.

The free Real Player basic is required in order to connect to this broadcast.

Other Hearing Documents

Panel 1
Rev. and Mrs. Edwin Rode 405 Brookwood Drive Athens, Georgia, 30605

Panel 2
Dr. Donald Vereen Office of National Drug Control Policy Executive Office of the President Washington, DC, 20503	Ms. Laura Nagel Drug Enforcement Administration 700 Army Navy Drive Arlington, Virginia, 22202
Ms. Elizabeth Durant U.S. Customs Service Customs Headquarters, Room 4.4A 1300 Pennsylvania Ave., N.W Washington, DC, 20229	Mr. William Hubbard Food and Drug Administration 5600 Fishers Lane Rockville, Maryland, 20857
Dr. Alan I. Leshner Director National Institute on Drug Abuse 6001 Executive Boulevard, Suite 524 Bethesda, Maryland, 20892	Mr. Landon Gibbs First Sergeant Virginia State Police P.O. Box 978 Salem, Virginia, 24153

Panel 3
Dr. Marven Shepherd Prefessor University of Texas Campus Mail Code: A 193 Austin, Texas, 78712	Dr. John D. Glover Vice President, Corporate Security Bristol-Myers Squibb Company 655 15th Street, N.W., Suite 300 Washington, D.C., 20005
Mr. James Christian Vice President and Head of Corporate Security Novartis International AG 701 Pennsylvania Avenue, N.W., Suite 725 Washington, D.C., 20004	Mr. William Trundley Vice President Corporate Security and Investigations GlaxoSmithKline 1500 K Street, N.W., Suite 650 Washington, D.C., 20005
Mr. Gene R. Haislip P.O. Box 941 Leesburg, Virginia, 20178	Mr. Donald deKieffer deKieffer & Horgan 729 15th Street, N.W., Suite 800 Washington, D.C., 20005